EP 117: Designing Open-Source Medical Software | Maya Friedman & Kelly Watson

On today's episode, we are going to talk about designing open source medical software. 

Maya Friedman is a digital product design lead and art director who designs solutions for unmet needs in the health tech and femtech spaces. She currently leads the user experience, visual and sonic design for Tidepool's FDA-cleared, automated insulin dosing mobile application, Tidepool Loop. She is also the founder of The Period Project, which supports the creation of an ecosystem of software solutions, research initiatives, and education to address the unmet needs of women+ with diabetes, through the different phases of a woman’s life cycle including menstruation and pregnancy. Prior to joining Tidepool, Maya was a creative lead for Allbodies Health, designing education to improve sex, mind and body literacy. She also worked as a creative at Made Music Studios, driving the design and strategy for digital-audio experiences, most notably leading a partnership with the Cooper Hewitt Design Museum to develop an audio-first design exhibition around alarm fatigue in hospital settings. She thrives leading a team of product designers, illustrators, user researchers and sound designers to design solutions for topics such as health and body literacy, menstrual health and alarm fatigue. Maya has her MFA in Media Design practices with a focus on femtech and sextech design from ArtCenter College of Design.

Kelly Watson is VP, Product & User Experience for Tidepool, a digital health nonprofit building solutions for people with diabetes. Kelly has worked to ensure the patient, the clinician and care partners are at the center of the product design process, leading Tidepool to achieve rapid market adoption growing its global ecosystem to over 450,000 people with diabetes and 12,000 clinicians. At Tidepool, she has led partnerships with many of the world’s largest diabetes medical device companies and technology companies. Previously Kelly worked in bench research at the Center for Biologics Evaluation and Research, FDA (CBER-OVRR DVP) and the National Institute of Mental Health prior to building out a product design consultancy. She is an angel investor and advisor for emerging digital health startups. Kelly advocates for patient ownership of health data, interoperability and open healthcare standards.

Episode mentions and links:

https://www.tidepool.org

Tidepool loop has received FDA clearance

Tidepool loop origin story

Tidepool: Ways to give

Maya’s restaurant rec: Saffy’s

Kelly’s restaurant rec: Hook Fish Co.

Follow Maya: LinkedIn | Instagram

Follow Kelly: LinkedIn | Twitter

Episode Website: https://www.designlabpod.com/episodes/117

Episode Reflection

This week’s episode was a personal one for me so I was excited to put on my co-host hat and join the discussion around technology for managing insulin dependent diabetes. I was diagnosed with Type 1 diabetes late in life at the age of 26. I had just graduated pharmacy school and started my first job as a pharmacist at the Children’s Hospital of Philadelphia. After a bout of nasty back-to-back illnesses, something common for people working in a pediatric hospital for the first time, I began to exhibit a group of symptoms that resembled something I had l learned about in my studies. Frequent urination, unquenchable thirst, mood swings, and extreme tiredness. I found myself falling asleep in my chair during the workday and tried to attribute it to needing more sleep. I joke about how I realized something was wrong with me when my parents came to visit and I found myself having to use the bathroom more frequently than my 60-something-year-old mother. 

I dug out the glucometer I was given in pharmacy school to learn about diabetes self-care. A right of passage for many pharmacy students learning self-care is to “pretend” they have diabetes for a week, testing their blood sugars and documenting them multiple times a day, to experience how difficult the things we ask our patients to do really are. A quick finger prick confirmed exactly what I feared but deep down already knew was true. My blood glucose was in the 200s. I had diabetes, and thanks to being a pharmacist, I knew exactly what that meant. Later the same month I received my own diagnosis, a close friend from college who had Type 1 diabetes from childhood, Peter Millin, died from complications relating to his diabetes. In my grief, I saw my future laid bare before me, years of struggling with managing this life-altering chronic illness, an early death. Could my story be different from Pete’s?

The answer is YES. Thanks to people and groups like Tidepool, advancements in medicine and technology mean that today, it is more possible than ever to have a long and healthy life with diabetes. When I was diagnosed, my treatment meant finger sticks and multiple daily injections with two kinds of insulin. I was plagued by highs and lows thanks to a lack of information that simply could not replace the functionality my body had lost with my disease. Today, my continuous glucose sensor gives me a 24-hour view of my glucose levels and my insulin pump holds 3 days of insulin and automatically adjusts itself to keep my blood glucose in range. It’s incredible to imagine that in the span of a century, diabetes has gone from a certain death sentence to one where a functional cure is on the horizon. We owe it to those who were born too soon to benefit from the technologies we have today, to keep pushing for a cure. To keep improving the tools that we already have access to and to have the audacity to imagine a future entirely unrecognizable from the reality of today. In this week’s episode, we talked a lot about agency and the power of design to return agency to people. I hope stories like the ones we spoke about in today’s episode will inspire a generation of designers to work in health design and strive to return agency to people using the principle of good human-centered design. We don’t have a cure yet, BUT there is SO MUCH MORE we can do to improve the lives of people suffering from chronic disease TODAY simply by designing better products, services, and spaces and making lives better.

Written by Rob Pugliese

Previous
Previous

EP 118: Designing Health Equity | Adriane Ackerman & Robert Fabricant

Next
Next

EP 116: Designing Hope in American Medicine | Ricardo Nuila